Filter
5246
Filtered Results: 5246
Text search:
non
communicable
diseases
Featured
Recommendations
464
New Publications
1201
Language
Document type
No document type
2479
Studies & Reports
1071
Guidelines
670
Manuals
308
Strategic & Response Plan
254
Fact sheets
141
Training Material
99
Infographics
62
Resource Platforms
51
Situation Updates
35
Videos
26
Brochures
19
Dashboards/Maps
15
Online Courses
15
App
1
Countries / Regions
Global
552
India
191
South Africa
148
Kenya
142
Africa
128
Western and Central Europe
107
Ethiopia
103
Sierra Leone
102
Liberia
91
Latin America and the Carribbean
89
Uganda
82
Nepal
81
Nigeria
79
Malawi
70
Bangladesh
66
Myanmar / Burma
64
Ghana
60
Rwanda
57
Zambia
56
Syria
55
Tanzania
52
South–East Asia Region
52
Ukraine
51
Philippines
43
Indonesia
43
Congo, Democratic Republic of
42
Asia
40
Namibia
40
Eastern Europe
36
Lesotho
30
Mozambique
30
East and Southern Africa
29
Cambodia
28
West and Central Africa
28
Zimbabwe
24
Guinea
24
Eastern Europe and Central Asia
22
South Sudan
21
Germany
19
Middle East and North Africa
19
Russia
19
North America
18
Pakistan
18
Botswana
17
Western Pacific Region
16
Brazil
15
Senegal
14
Afghanistan
13
Haiti
13
Yemen
13
Eswatini/ Swaziland
13
Iraq
12
Burkina Faso
11
Venezuela
11
Thailand
10
Moldova
10
Colombia
9
USA
9
Jordan
9
Vietnam
9
Sudan
9
Somalia
9
Laos
8
United Kingdom
7
Lebanon
7
Papua New Guinea
7
Turkey
6
Benin
6
China
6
Cameroon
6
Kyrgyzstan
6
Paraguay
6
Sri Lanka
6
Palestine
6
Tajikistan
5
Iran
5
Peru
5
Saudi Arabia
5
Argentina
5
Angola
5
Kazakhstan
4
Chile
4
Spain
4
Southern Africa
4
Georgia
4
Central African Republic
4
Timor Leste/ East Timor
3
Albania
3
Turkmenistan
3
Jamaica
3
Mauritius
3
Portugal
3
Belarus
3
Bosnia and Herzegovina
3
Bolivia
3
Greece
3
Poland
3
Madagascar
3
North Macedonia
2
Mexico
2
El Salvador
2
Serbia
2
Gambia
2
Togo
2
Canada
2
Fiji
2
Guinea-Bissau
2
Croatia
2
Hungary
2
Japan
2
Azerbaijan
2
Côte d’Ivoire / Ivory Coast
2
Egypt
2
Romania
2
Mali
2
Bhutan
2
Switzerland
1
Singapore
1
Estonia
1
Niger
1
Burundi
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Italy
1
Armenia
1
Ireland
1
Gabon
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Israel
1
Latvia
1
Barbados
1
United Arab Emirates
1
Djibouti
1
Honduras
1
Libya
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1833
Public Health
863
Clinical Guidelines
410
Key Resources
259
Women & Child Health
208
Capacity Building
137
Pharmacy & Technologies
45
Annual Report MEDBOX
2
Toolboxes
NCDs
748
COVID-19
412
Mental Health
374
HIV
245
TB
221
Planetary Health
204
Rapid Response
171
Disability
152
Caregiver
152
Conflict
129
Global Health Education
129
AMR
118
Ebola & Marburg
117
NTDs
108
Refugee
73
Natural Hazards
66
Pharmacy
61
Health Financing Toolbox
39
Zika
29
Polio
26
Specific Hazards
23
Cholera
22
Social Ethics
13
South Sudan
1
Typhoon
1
The document addresses the pressing issues of global malnutrition and the urgent need to build workforce capacity in public health nutrition, particularly in low- and middle-income countries. It highlights the dual burden of malnutrition, characterized by the coexistence of undernutrition and overnu...
The IHME webpage discusses alcohol use as a significant global health risk, responsible for over 1.8 million deaths annually. It highlights age-related differences in alcohol's health impacts, with no benefits for individuals aged 15–39 and potential small benefits for those aged 40 and above unde...
Physical activity plays an important role in the care of people living type 2 diabetes. Regular physical
activity can help reduce some of the harmful effects and slow or even reverse disease progression.
Being active can also reduce symptoms of depression and anxiety, and enhance thinking, learnin...
The article "Air Pollution: The Emergence of a Major Global Health Risk Factor" discusses the significant health impacts of air pollution, a leading risk factor for global mortality. It highlights the adverse effects of fine particulate matter (PM2.5) and tropospheric ozone, linking them to cardiova...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against...
On the 31st December 2019, the World Health Organization (WHO) China country office reported a cluster of pneumonia cases in Wuhan City, Hubei Province of China now known to be caused by a novel virus. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been confirmed as the causative v...
It is intended for use among clinicians taking care of moderate to severe COVID-19 cases.
The COVID-19 outbreak has brought with it the need for improved critical care for patients who develop severe disease. The majority of COVID-19 patients present with mild to moderate illness, 15% develop sever...
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ...
Mass population movements have accounted for the emergence of Chagas disease (CD) outside endemic regions,
including the European Union/European Economic Area (EU/EEA). The parasite responsible for causing CD,
Trypanosoma cruzi (T. cruzi), can be transmitted through substances of human origin (SoH...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristicall...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and control for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infr...
The checklist tool described in this handbook is intended for EU/EEA public health authorities who need to assess the capacity for communicable disease prevention and control at migrant reception/detention centres hosting migrants for weeks/months (medium-term) in order to identify gaps and set prio...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
This companion document to Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030 ("the road map") aims to support a range of stakeholders - including countries in which neglected tropical diseases (NTDs) are endemic, international organi...
The document provides the NICE Quality Standard for managing Type 2 diabetes in adults (QS209). It outlines evidence-based recommendations for preventing Type 2 diabetes, structured education, continuous glucose monitoring (CGM), medication such as SGLT2 inhibitors, and regular care processes to mon...
Communicable Disease Control Branch
Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
